202 related articles for article (PubMed ID: 19494663)
1. A practical approach to problems of hypercalcaemia.
Davies JH
Endocr Dev; 2009; 16():93-114. PubMed ID: 19494663
[TBL] [Abstract][Full Text] [Related]
2. Investigation and management of hypercalcaemia in children.
Davies JH; Shaw NJ
Arch Dis Child; 2012 Jun; 97(6):533-8. PubMed ID: 22447996
[TBL] [Abstract][Full Text] [Related]
3. The role of the extracellular calcium-sensing receptor in health and disease.
Raue F; Haag C; Schulze E; Frank-Raue K
Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):397-405. PubMed ID: 17039419
[TBL] [Abstract][Full Text] [Related]
4. [Determination of plasma parathyroid hormone in the differential diagnosis of hypercalcemias associated with malignant tumors].
Gasser AB; Burckhardt P
Schweiz Med Wochenschr; 1978 Jul; 108(27):1031-4. PubMed ID: 663597
[TBL] [Abstract][Full Text] [Related]
5. The pathophysiology of primary hyperparathyroidism.
Brown EM
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N24-9. PubMed ID: 12412774
[TBL] [Abstract][Full Text] [Related]
6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
7. Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.
Ward BK; Magno AL; Blitvich BJ; Rea AJ; Stuckey BG; Walsh JP; Ratajczak T
Clin Endocrinol (Oxf); 2006 May; 64(5):580-7. PubMed ID: 16649980
[TBL] [Abstract][Full Text] [Related]
8. Effects of calcium-sensing receptor on the secretion of parathyroid hormone-related peptide and its impact on humoral hypercalcemia of malignancy.
Chattopadhyay N
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E761-70. PubMed ID: 16603723
[TBL] [Abstract][Full Text] [Related]
9. Clinical disorders of extracellular calcium-sensing and the molecular biology of the calcium-sensing receptor.
Pearce SH
Ann Med; 2002; 34(3):201-6. PubMed ID: 12173690
[TBL] [Abstract][Full Text] [Related]
10. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone-related protein (PTHrP) gene expression in solid tumours associated with normocalcaemia and hypercalcaemia.
Dunne FP; Lee S; Ratcliffe WA; Hutchesson AC; Bundred NJ; Heath DA
J Pathol; 1993 Nov; 171(3):215-21. PubMed ID: 8277370
[TBL] [Abstract][Full Text] [Related]
12. Associations of vitamin D receptor, calcium-sensing receptor and parathyroid hormone gene polymorphisms with calcium homeostasis and peripheral bone density in adult Finns.
Laaksonen MM; Outila TA; Karkkainen MU; Kemi VE; Rita HJ; Perola M; Valsta LM; Lamberg-Allardt CJ
J Nutrigenet Nutrigenomics; 2009; 2(2):55-63. PubMed ID: 19690432
[TBL] [Abstract][Full Text] [Related]
13. The clinical utility of parathyroid hormone-related peptide in the assessment of hypercalcemia.
Fritchie K; Zedek D; Grenache DG
Clin Chim Acta; 2009 Apr; 402(1-2):146-9. PubMed ID: 19168044
[TBL] [Abstract][Full Text] [Related]
14. Hypercalcemia of cancer: an update.
Goni MH; Tolis G
Anticancer Res; 1993; 13(4):1155-60. PubMed ID: 8352538
[TBL] [Abstract][Full Text] [Related]
15. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
[TBL] [Abstract][Full Text] [Related]
16. Circadian variation of the Ca2+ -PTH curve during hypercalcaemia in dogs.
Domingo V; López I; Mendoza FJ; Rodríguez M; Aguilera-Tejero E; Estepa JC
J Vet Med A Physiol Pathol Clin Med; 2007 Dec; 54(10):545-8. PubMed ID: 18045336
[TBL] [Abstract][Full Text] [Related]
17. A practical approach to hypocalcaemia in children.
Shaw N
Endocr Dev; 2009; 16():73-92. PubMed ID: 19494662
[TBL] [Abstract][Full Text] [Related]
18. PTH-independent hypercalcaemia and non-melanoma skin cancer.
Nicolae I; Schipor S
J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):449-52. PubMed ID: 19778357
[TBL] [Abstract][Full Text] [Related]
19. Effects of acute hypercalcaemia on blood pressure in subjects with and without parathyroid hormone secretion.
Kamycheva E; Jorde R; Haug E; Sager G; Sundsfjord J
Acta Physiol Scand; 2005 Jun; 184(2):113-9. PubMed ID: 15916671
[TBL] [Abstract][Full Text] [Related]
20. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia.
Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE
Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
